Close
Close
Treatment Database
(2S,4R)-1-(2-(3-acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromopyridin-2-yl)-4-fluoropyrrolidine-2-carboxamide
Trade Name not avaiable
Orphan Indication Paroxysmal nocturnal hemoglobinuria
USA Market Approval
USA Designation Date 02-11-2017
Sponsor Achillion Pharmaceuticals, Inc
300 George Street
New Haven, Connecticut, 06511
More about Hemoglobinuria
Free Newsletter
Videos
by Abidemi Uruejoma
7 views
by Scott Harwood
7 views
by Scott Harwood
6 views
by Abidemi Uruejoma
32 views
by Scott Harwood
24 views